Question 1

What are the most cited papers from GenoSafe?

Accepted Answer

The most cited paper from GenoSafe is "Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy" (Nathalie Cartier et al., 2009), with 1,526 citations. Next come "Large-Scale Manufacture and Characterization of a Lentiviral Vector Produced for Clinical Ex Vivo Gene Therapy Application" (185) and "Determination of Anti-Adeno-Associated Virus Vector Neutralizing Antibody Titer with an In Vitro Reporter System" (115).

Question 2

Which research topics does GenoSafe publish most on?

Accepted Answer

By volume in 2022-now: Water Resource Management and Quality, Virus-based gene therapy research, CAR-T cell therapy research and Viral Infectious Diseases and Gene Expression in Insects.

Question 3

Which fields of science does GenoSafe work in?

Accepted Answer

In all years, 65% of research at GenoSafe is in Life Sciences, 26% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (50%), Medicine (26%), Environmental Science (8%). It does 1.8× the world's share of Life Sciences.

Question 4

Is GenoSafe's research output growing?

Accepted Answer

Output in 2022-2025 was 332% higher than in 2018-2021.